List of small geographic areas included in this cancer report

List of small geographic areas Cancer incidence statistics are available for the following areas

Cancer incidence statistics are available by Statistical Area Level 3 (SA3) and in future releases the small geographic area content is expected to include cancer incidence data by Primary Health Network and Local Government Area. 

For the SA3 incidence data, the range of cancer information and depth depends on the number of cancer cases diagnosed within the area. Where there are insufficient numbers of cases, data is not presented. The list of SA3 locations with cancer data in this report are provided below with the list also including the cancer types that are included in reporting for the respective SA3 location.

The cancer incidence by SA3 data are available in the Cancer statistics by Statistical Area 3 page. It includes cancer cases and rates between 2011 to 2021.

Please note, this page is very long and uses a find function for the location you wish to find cancer stats for should be the most efficient way to locate the cancers reported on for the particular location.

List of Statistical Area 3 with cancer incidence statistics and the cancers available

SA3 and state

Cancers included

Adelaide City (SA)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - uterine cancer .

Adelaide Hills (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Albany (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Albury (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Alice Springs (NT)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Armadale (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Armidale (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer - vulvar cancer .

Auburn (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Augusta - Margaret River - Busselton (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Bald Hills - Everton Park (QLD)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Ballarat (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Bankstown (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other blood cancers - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Banyule (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Barkly (NT)

all cancers combined - breast cancer - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) .

Barossa (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Barwon - West (VIC)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - thyroid cancer - uterine cancer .

Bathurst (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Baulkham Hills (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Baw Baw (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Bayside (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Bayswater - Bassendean (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Beaudesert (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Beenleigh (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Belconnen (ACT)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Belmont - Victoria Park (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Bendigo (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Biloela (QLD)

all blood cancers combined - all cancers combined - bladder cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - thyroid cancer - uterine cancer .

Blacktown (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Blacktown - North (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Blue Mountains (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Boroondara (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Botany (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Bourke - Cobar - Coonamble (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Bowen Basin - North (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Bribie - Beachmere (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Brighton (TAS)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - uterine cancer .

Brimbank (VIC)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other blood cancers - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Bringelly - Green Valley (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Brisbane Inner (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Brisbane Inner - East (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Brisbane Inner - North (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Brisbane Inner - West (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Broadbeach - Burleigh (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Broken Hill and Far West (NSW)

all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (Breslow > 4mm) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Browns Plains (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Brunswick - Coburg (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Buderim (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Bunbury (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Bundaberg (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other blood cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Burnett (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Burnie - Ulverstone (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Burnside (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Caboolture (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Caboolture Hinterland (QLD)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - tongue cancer - uterine cancer .

Cairns - North (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Cairns - South (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Caloundra (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Camden (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Campaspe (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Campbelltown (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Campbelltown (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Canada Bay (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Canberra East (ACT)

all cancers combined - higher survival cancers (5yr survival above 90%) - low survival cancers (5yr survival below 30%) - rare and less common cancers (2025) combined - rare cancers (2025) .

Canning (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Canterbury (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Capalaba (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Cardinia (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Carindale (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Carlingford (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Casey - North (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Casey - South (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Centenary (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Central Highlands (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Central Highlands (TAS)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - thyroid cancer - uterine cancer .

Charles Sturt (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other plasma cell cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Charters Towers - Ayr - Ingham (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Chatswood - Lane Cove (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Chermside (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Christmas Island (OTH)

all cancers combined - higher survival cancers (5yr survival above 90%) - prostate cancer .

Clarence Valley (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Cleveland - Stradbroke (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Cockburn (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Cocos (Keeling) Islands (OTH)

all cancers combined - higher survival cancers (5yr survival above 90%) .

Coffs Harbour (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Colac - Corangamite (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Coolangatta (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Cottesloe - Claremont (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Creswick - Daylesford - Ballan (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - immunoproliferative cancers - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Cronulla - Miranda - Caringbah (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Daly - Tiwi - West Arnhem (NT)

all blood cancers combined - all cancers combined - bladder cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - oesophageal cancer - oropharyngeal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - thyroid cancer - tongue cancer - uterine cancer .

Dandenong (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Dapto - Port Kembla (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Darebin - North (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Darebin - South (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Darling Downs (West) - Maranoa (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Darling Downs - East (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Darwin City (NT)

all blood cancers combined - all cancers combined - bladder cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Darwin Suburbs (NT)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Devonport (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Dubbo (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Dural - Wisemans Ferry (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - uterine cancer .

East Arnhem (NT)

all blood cancers combined - all cancers combined - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - neuroendocrine neoplasms - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - thyroid cancer - uterine cancer .

East Pilbara (WA)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - neuroendocrine neoplasms - non-Hodgkin lymphoma - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - thyroid cancer .

Eastern Suburbs - North (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Eastern Suburbs - South (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Esperance (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - mesothelioma - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - thyroid cancer - tongue cancer .

Essendon (VIC)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Eyre Peninsula and South West (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer .

Fairfield (NSW)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Far North (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - mouth cancer - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Fleurieu - Kangaroo Island (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Forest Lake - Oxley (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Frankston (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Fremantle (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Gascoyne (WA)

all blood cancers combined - all cancers combined - bladder cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) .

Gawler - Two Wells (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Geelong (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Gippsland - East (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Gippsland - South West (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Gladstone (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Glen Eira (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Glenelg - Southern Grampians (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Gold Coast - North (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Gold Coast Hinterland (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Goldfields (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Gosford (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other blood cancers - other central nervous system cancers - other plasma cell cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vaginal cancer - vulvar cancer .

Gosnells (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Goulburn - Mulwaree (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Grampians (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Granite Belt (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Great Lakes (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Griffith - Murrumbidgee (West) (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Gungahlin (ACT)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Gympie - Cooloola (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Hawkesbury (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - uterine cancer .

Heathcote - Castlemaine - Kyneton (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Hervey Bay (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Hobart - North East (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Hobart - North West (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Hobart - South and West (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Hobart Inner (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Hobsons Bay (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Holdfast Bay (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Holland Park - Yeronga (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Hornsby (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Huon - Bruny Island (TAS)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Hurstville (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Innisfail - Cassowary Coast (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Inverell - Tenterfield (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Ipswich Hinterland (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Ipswich Inner (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Jervis Bay (OTH)

all cancers combined .

Jimboomba (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Joondalup (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Kalamunda (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Katherine (NT)

all blood cancers combined - all cancers combined - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - mouth cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - oropharyngeal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - thyroid cancer .

Keilor (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Kempsey - Nambucca (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Kenmore - Brookfield - Moggill (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Kiama - Shellharbour (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Kimberley (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - mouth cancer - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Kingston (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Knox (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Kogarah - Rockdale (NSW)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Ku-ring-gai (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other plasma cell cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Kwinana (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Lachlan Valley (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Lake Macquarie - East (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Lake Macquarie - West (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Latrobe Valley (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Launceston (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Leichhardt (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Limestone Coast (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Litchfield (NT)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Lithgow - Mudgee (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Liverpool (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Loddon - Elmore (VIC)

all blood cancers combined - all cancers combined - bladder cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - uterine cancer .

Loganlea - Carbrook (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Lord Howe Island (NSW)

all cancers combined - higher survival cancers (5yr survival above 90%) .

Lower Hunter (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Lower Murray (NSW)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (Breslow > 4mm) - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - uterine cancer .

Lower North (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - uterine cancer .

Macedon Ranges (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Mackay (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Maitland (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Mandurah (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Manjimup (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Manly (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Manningham - East (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Manningham - West (VIC)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Maribyrnong (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Marion (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Maroochy (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Maroondah (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Marrickville - Sydenham - Petersham (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Maryborough (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Maryborough - Pyrenees (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Meander Valley - West Tamar (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Melbourne City (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Melton - Bacchus Marsh (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Melville (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Merrylands - Guildford (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Mid North (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Mid West (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Mildura (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Mitcham (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Moira (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Molonglo (ACT)

all blood cancers combined - all cancers combined - breast cancer - gynaecological cancers - higher survival cancers (5yr survival above 90%) - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) .

Monash (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Moree - Narrabri (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Moreland - North (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Mornington Peninsula (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - sinuses cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Mount Druitt (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other blood cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Mt Gravatt (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Mudgeeraba - Tallebudgera (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Mundaring (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Murray River - Swan Hill (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Murray and Mallee (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Nambour (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Narangba - Burpengary (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Nathan (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Nerang (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Newcastle (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Nillumbik - Kinglake (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Noosa (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Noosa Hinterland (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

North Canberra (ACT)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

North East (TAS)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

North Lakes (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

North Sydney - Mosman (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Norwood - Payneham - St Peters (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Nundah (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Onkaparinga (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Orange (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Ormeau - Oxenford (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other blood cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vaginal cancer - vulvar cancer .

Outback - North (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (2mm < Breslow <= 4mm) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Outback - North and East (SA)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - thyroid cancer - uterine cancer .

Outback - South (QLD)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Palmerston (NT)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Parramatta (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Pennant Hills - Epping (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Penrith (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Perth City (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Pittwater (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Playford (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Port Adelaide - East (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Port Adelaide - West (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Port Douglas - Daintree (QLD)

all blood cancers combined - all cancers combined - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Port Macquarie (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vaginal cancer - vulvar cancer .

Port Phillip (VIC)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Port Stephens (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Prospect - Walkerville (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Queanbeyan (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Redcliffe (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Richmond - Windsor (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Richmond Valley - Coastal (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Richmond Valley - Hinterland (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Robina (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Rockhampton (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Rockingham (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Rocklea - Acacia Ridge (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Rouse Hill - McGraths Hill (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - mesothelioma - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

Ryde - Hunters Hill (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Salisbury (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Sandgate (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - hypopharyngeal cancer - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Serpentine - Jarrahdale (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - mesothelioma - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Shepparton (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Sherwood - Indooroopilly (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Shoalhaven (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Snowy Mountains (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Sorell - Dodges Ferry (TAS)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

South Canberra (ACT)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - uterine cancer .

South Coast (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

South East Coast (TAS)

all blood cancers combined - all cancers combined - bladder cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - uterine cancer .

South Perth (WA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Southern Highlands (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Southport (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Springfield - Redbank (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Springwood - Kingston (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

St Marys (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Stirling (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other plasma cell cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Stonnington - East (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Stonnington - West (VIC)

Kaposi sarcoma - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Strathfield - Burwood - Ashfield (NSW)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Strathpine (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Sunbury (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Sunnybank (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Sunshine Coast Hinterland (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Surf Coast - Bellarine Peninsula (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Surfers Paradise (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Sutherland - Menai - Heathcote (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Swan (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Sydney Inner City (NSW)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other endocrine glands - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - sinuses cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Tablelands (East) - Kuranda (QLD)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Tamworth - Gunnedah (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Taree - Gloucester (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Tea Tree Gully (SA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

The Gap - Enoggera (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

The Hills District (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Toowoomba (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Townsville (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vaginal cancer - vulvar cancer .

Tuggeranong (ACT)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Tullamarine - Broadmeadows (VIC)

Kaposi sarcoma - acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Tumut - Tumbarumba (NSW)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - uterine cancer .

Tweed Valley (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Unley (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Upper Goulburn Valley (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Upper Hunter (NSW)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Upper Murray exc. Albury (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Uriarra - Namadgi (ACT)

all cancers combined .

Wagga Wagga (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Wangaratta - Benalla (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Wanneroo (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Warringah (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Warrnambool (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Wellington (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

West Coast (TAS)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - thyroid cancer - uterine cancer .

West Pilbara (WA)

all blood cancers combined - all cancers combined - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - mesothelioma - neuroendocrine neoplasms - non-Hodgkin lymphoma - oesophageal cancer - oropharyngeal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - thyroid cancer - tongue cancer - uterine cancer .

West Torrens (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Weston Creek (ACT)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Wheat Belt - North (WA)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Wheat Belt - South (WA)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - mesothelioma - multiple myeloma - myelodysplastic syndromes - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - thyroid cancer - uterine cancer .

Whitehorse - East (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Whitehorse - West (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Whitsunday (QLD)

all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Whittlesea - Wallan (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vulvar cancer .

Woden Valley (ACT)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - leukaemia - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Wodonga - Alpine (VIC)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Wollondilly (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer .

Wollongong (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Wyndham (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Wynnum - Manly (QLD)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Wyong (NSW)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of other thoracic and respiratory organs - cancer of other endocrine glands - cancer of other and ill-defined sites - cancer of unknown primary site - cancer of overlapping and unspecified sites in biliary tract - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - extrahepatic bile duct cancer - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - hypopharyngeal cancer - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - nasal cavity cancer - nasopharyngeal cancer - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - penile cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - retroperitoneal and peritoneal cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - ureteral cancer - uterine cancer - vaginal cancer - vulvar cancer .

Yarra (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Yarra Ranges (VIC)

acute lymphoblastic leukaemia - acute myeloid leukaemia - all blood cancers combined - all cancers combined - ampullary cancer - anal cancer - appendiceal cancer - bladder cancer - bone cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of other and ill-defined digestive organs - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - chronic myeloid leukaemia (CML) - colorectal cancer (bowel cancer) - eye cancer - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - other and unspecified lymphoid leukaemia - other central nervous system cancers - ovarian cancer and cancer of other female genital organs - pancreatic cancer - parotid gland cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - renal pelvis cancer - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Yorke Peninsula (SA)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - cervical cancer - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gallbladder cancer - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - thyroid cancer - tongue cancer - uterine cancer .

Young - Yass (NSW)

acute myeloid leukaemia - all blood cancers combined - all cancers combined - bladder cancer - brain cancer - breast cancer - breast cancer (tumour size <= 2cm) - breast cancer (2cm < tumour size <= 5cm) - breast cancer (tumour size > 5cm) - breast cancer (tumour size unknown) - cancer of unknown primary site - cancer of connective, subcutaneous and other soft tissues - chronic lymphocytic leukaemia - colorectal cancer (bowel cancer) - gynaecological cancers - head and neck cancer (excluding lip) - higher survival cancers (5yr survival above 90%) - Hodgkin lymphoma - immunoproliferative cancers - kidney cancer - laryngeal cancer - leukaemia - lip cancer - liver cancer - low survival cancers (5yr survival below 30%) - lung cancer - melanoma of the skin - melanoma of the skin (Breslow <= 1mm) - melanoma of the skin (1mm < Breslow <= 2mm) - melanoma of the skin (2mm < Breslow <= 4mm) - melanoma of the skin (Breslow > 4mm) - melanoma of the skin (Breslow unknown) - mesothelioma - mouth cancer - multiple myeloma - myelodysplastic syndromes - myeloproliferative neoplasms (excluding CML) - neuroendocrine neoplasms - non-Hodgkin lymphoma - non-melanoma skin cancer (rare types) - oesophageal cancer - oropharyngeal cancer - ovarian cancer and cancer of other female genital organs - pancreatic cancer - prostate cancer - rare and less common cancers (2025) combined - rare cancers (2025) - small intestine cancer - soft tissue sarcoma - stomach cancer - testicular cancer - thyroid cancer - tongue cancer - uterine cancer - vulvar cancer .

Previous page
Next page